ADHD drugs don’t raise risk for heart attacks or stroke: Study

Published on November 2, 2011 at 8:00 PM · 1 Comment

By Dr Ananya Mandal, MD

Drugs known as stimulants, that are used to treat attention deficit hyperactivity disorder do not increase the risk of heart attacks, strokes or sudden death, U.S. researchers said on Monday. This study finding should reassure millions of parents whose children take the drugs.

For the study, Cooper's team used prescription data from four large, geographically and demographically diverse health plans on 1,200,438 children and youth (aged between 2 and 24), including both current and past users of the drugs Ritalin or Adderall. They checked health records for evidence of heart problems, including heart attacks, strokes and sudden cardiac deaths, in children who were currently taking the drugs or who had taken them.

The team found no increased risk of heart problems for either current or past users of the drugs. Yet because there were so few cases of serious heart problems - just 81 - the study may not have been large enough to detect it.

“We don't see any evidence of increased risk,” said Dr. William Cooper of Vanderbilt University, whose study was published in the New England Journal of Medicine.

This study is one of the three commissioned by the Food and Drug Administration to understand the potential heart risks of the drugs after U.S. and Canadian regulators received a number of reports in 2006 of heart attacks, strokes and sudden cardiac arrest in children taking the medications.

The reports prompted several FDA advisory committee hearings on heart problems, and Health Canada temporarily suspended marketing of ADHD drugs. The concerns also prompted the American Heart Association to issue guidelines suggesting that children who were just starting to take the drugs should be tested for potential underlying heart problems.

“There was a lot of concern and confusion among families and providers about what the best approach would be to treating kids who had ADHD and who might benefit from these medicines,” Cooper explained.

ADHD is one of the most common child mental disorders, affecting around 3 to 5 percent of children globally. Children with ADHD are excessively restless, impulsive and easily distracted, and often have trouble at home and in school. There is no cure, but the symptoms can be kept in check by a combination of behavioral therapy and medication. In the United States, some 2.7 million children have prescriptions for ADHD drugs including Novartis' Ritalin or methylphenidate and Focalin; Johnson & Johnson's Concerta, Shire's Adderall and Vyvanse and Eli Lilly's Strattera.

But even if there were a risk of heart problems, it is extremely slight, Cooper said. In a guidance document issued on Tuesday, the FDA said it continues to recommend that the drugs not be used in patients with serious heart problems. It added that patients should be monitored for changes in heart rate or blood pressure.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
  1. E.M. Wollof E.M. Wollof United States says:

    These studies cover up the true harm that can come from giving these medications to children. There are many times that death doesn't happen physically, but is very real mentally. I found this video that illustrates the point rather well: http://www.youtube.com/watch?v=BLFeaX0eioM

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Regeneron announces FDA approval of EYLEA Injection for DME treatment